2018
DOI: 10.1016/j.jpainsymman.2018.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Magnetic Resonance–Guided Focused Ultrasound Surgery for Bone Metastasis: From Pain Palliation to Biological Ablation?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 26 publications
0
5
0
Order By: Relevance
“…The duration of survival observed in this study is slightly longer than the reported median survival of 7 months by Duangmani ( 20 ), possibly due to the separate analysis conducted in our study for isolated bone metastasis and multi-organ metastasis. Various treatment methods, including conventional radiotherapy, stereotactic body radiotherapy ( 21 ), and Magnetic Resonance-Guided Focused Ultrasound Surgery ( 22 ), are effective in achieving tumor control and biological ablation for the treatment of bone metastasis. Additionally, the use of osteoclast inhibitors can help reduce the risk of bone fractures ( 23 ).…”
Section: Discussionmentioning
confidence: 99%
“…The duration of survival observed in this study is slightly longer than the reported median survival of 7 months by Duangmani ( 20 ), possibly due to the separate analysis conducted in our study for isolated bone metastasis and multi-organ metastasis. Various treatment methods, including conventional radiotherapy, stereotactic body radiotherapy ( 21 ), and Magnetic Resonance-Guided Focused Ultrasound Surgery ( 22 ), are effective in achieving tumor control and biological ablation for the treatment of bone metastasis. Additionally, the use of osteoclast inhibitors can help reduce the risk of bone fractures ( 23 ).…”
Section: Discussionmentioning
confidence: 99%
“…382 Eisenberg et al described a cervical cancer patient who received magnetic resonance-guided focused ultrasound surgery (MRgFUS) for iliac bone metastasis. 383 In this case, MRgFUS led to a dramatic reduction in pain, and percutaneous cementoplasty was thus not considered. MRgFUS is a noninvasive surgical procedure that is effective in controlling bone metastasis-related pain in multiple clinical trials.…”
Section: Surgerymentioning
confidence: 91%
“…At 4-6 weeks after US-HIFU, no abnormal accumulation of activity at tumor sites [23]. In a patient with mixed lytic-sclerotic lesion at the iliac bone, no FDG uptake was observed at 3 months after MR-HIFU treatment (Figure 5) [32]; meanwhile, in a separate case study involving an osteolytic lesion at the iliac bone, a 35.1% decrease in standard uptake value (SUV) was noted at 3 months after MR-HIFU treatment [21], confirming tumor response in both cases. Using the PET response criteria in solid tumors (PERCIST 1.0), another study reported PR in 5 out of 12 patients and SD in 2 out of 12 patients; 4 out of 12 patients had PD at a median follow-up of 90 days after MR-HIFU [27].…”
Section: Treatment Of Bone Metastasismentioning
confidence: 96%